According to Edwards Lifesciences's latest financial reports the company's current revenue (TTM ) is ยฃ4.42 Billion. an increase over the revenue in the year 2023 that were of ยฃ4.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | ยฃ4.56 B | 5.04% |
2023 | ยฃ4.34 B | -2.39% |
2022 | ยฃ4.44 B | 14.77% |
2021 | ยฃ3.87 B | 20.46% |
2020 | ยฃ3.21 B | -2.95% |
2019 | ยฃ3.31 B | 13.06% |
2018 | ยฃ2.93 B | 15.38% |
2017 | ยฃ2.54 B | 5.83% |
2016 | ยฃ2.40 B | 42.74% |
2015 | ยฃ1.68 B | 12.78% |
2014 | ยฃ1.49 B | 20.32% |
2013 | ยฃ1.24 B | 5.51% |
2012 | ยฃ1.17 B | 8.82% |
2011 | ยฃ1.07 B | 15.22% |
2010 | ยฃ0.93 B | 14.79% |
2009 | ยฃ0.81 B | -3.3% |
2008 | ยฃ0.84 B | 53.76% |
2007 | ยฃ0.54 B | 3.71% |
2006 | ยฃ0.52 B | -8.49% |
2005 | ยฃ0.57 B | 19.26% |
2004 | ยฃ0.48 B | 0.87% |
2003 | ยฃ0.48 B | 9.56% |
2002 | ยฃ0.43 B | -8.01% |
2001 | ยฃ0.47 B | -14.52% |
2000 | ยฃ0.55 B |